Sahajanand Medical Technologies IPO analysis @ Chanakyanipothi.com , India`s Oldest & most Trusted Investment Blog.Operational since 8th December 1999, We are the Only Investment Platform in India, which has successfully completed 21 Years

Sahajanand Medical Technologies Grey Market News Today #
On
Grey Market Premium Rs. –
Application Rates :Rs. –
Subject to Rates : Rs. –

Sahajanand Medical Technologies Company Details
Sahajanand Medical Technologies is a leading medical devices company that researches, designs, develops, manufactures and markets vascular devices globally. It differentiates its product offering in these categories by providing its customers with high quality products at market appropriate prices supported by strong clinical data. This combination has led us to a leading market share in the drug eluting stent market in India, with a market share of 21%, 25% and 31% in Fiscals 2019, 2020 and 2021, respectively, of the total DES sales volume in India. It is among the top five companies in terms of market share in each of Germany, Netherlands, Italy and Poland, as of March 31, 2021 . It has a direct and distributor sales presence in more than 69 countries including direct presence in countries such as Germany, Poland, Spain, France, UK and Brazil.

Currently it offers products that are used in: (i) interventional cardiology, i.e., devices used for the treatment of blockages in heart vessels (coronary artery disease), such as coronary stents and catheters; (ii) structural heart therapy, i.e., devices used for treatment of abnormalities in the tissues, walls, and valves of the heart, such as transcatheter aortic valve implants (“TAVI”) and occluders; and (iii) peripheral intervention, i.e., devices used for treatment of blockages in the blood vessels other than those of the heart, such as renal stents. It has also launched one of the lowest strut thickness stents with a 60-micron thickness. It operates three research and development facilities, located
in Surat, India, Galway, Ireland and Nonthaburi, Thailand. As of March 31, 2021, we have been granted 67 patents globally with a pipeline of additional 17 patents and four design registrations in India.

The Company owns and operates two manufacturing facilities in India located at Surat and Bengaluru; and one overseas facility at Nonthaburi in Thailand where we manufacture products for structural heart therapy. For more information, click www.smtpl.com

The Promoters of Sahajanand Medical Technologies
Bhargav Dhirajlal Kotadia & Shree Hari Trust

Sahajanand Medical Technologies IPO Main Objects
The Offer comprises of the Fresh Issue and Offer for Sale.
The Company proposes to utilise the Net Proceeds towards
1. Repayment/ prepayment of certain indebtedness availed by the Company and its Subsidiaries;
2. Funding the working capital requirements of its indirect foreign subsidiary, Vascular Innovations Co. Ltd. (“Vascular Innovations”);

Sahajanand Medical Technologies IPO Details
IPO opens on (?) , 2022
IPO closes on (?) ,2022
Issue Type: Book Built Issue IPO
Issue : up to (?) Shares /Rs 1500 Crore
* Fresh Issue of (?) Sh/ Rs.410.33 Cr
* Offer for Sale Up to ? Sh/ Rs. 1089.67 Cr

Face Value per share : Rs. 1

Sahajanand Medical Technologies IPO Price Band Per Equity Share: Rs. (?)
Sahajanand Medical Technologies IPO Retail Lot Size (?) Shares
Sahajanand Medical Technologies Listing will at BSE,NSE

Shares offered to
QIB (?%) ?Shares = Rs (?) Cr
NII (?%) ?Shares = Rs (?) Crs
RII (?%) ? Shares = Rs (?) Crs
Lot size: (?) Shares = (?) Forms
Min Retail Application : (?) Sh , Rs. (?)
Max Retail Application : (?) Sh, Rs (?)

Sahajanand Medical Technologies IPO Tentative timeTable
Sahajanand Medical Technologies IPO Allotment on ? 2022
Unblocking of ASBA ? 2022
Credit to Demat Accounts ? 2022
Data Patterns Listing on ? 2022

Sahajanand Medical Technologies IPO Financial & Analytical Ratios
Earnings per Share 2019-20 Rs ( 8.13)
Earnings per Share 2020-21,Rs 2.76
Earnings per Share 2021-22 6M Rs ?
Book Value of the Share as on 31.3.2021 Rs 38.62
Return on Net Worth: 19-20 (21.06) %
Return on Net Worth: 20-21: 5.92 %
Return on Net Worth: 20-21 6M:( N.A.) %
Equity Shares prior to the IPO : 8,89,04,343 Shares

Ratio Analysis
Upper Price Band/last EPS:
Upper offer price/Book Value Ratio
Upper offer price/BV after IPO Ratio:

Sahajanand Medical Technologies IPO Peer Comparison:
None of the listed companies in India are engaged in business portfolio similar to this company
.

Sahajanand Medical Technologies IPO Lead Managers 
Axis Capital,BofA Securities, Edelweiss Financial Services, UBS Securities
Registrar to Ruchi Soya Industries IPO
Linkintime India pvt ltd.

Registered Office of Sahajanand Medical Technologies
Sahajanand Estate, Wakharia Wadi, NR. Dabholi Char Rasta, Nani Ved, Ved Road, Surat, Gujarat Company Secretary & Compliance Officer : Flora Das

#This is only coverage of News related to Grey Market . We donot deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.